Meridiem Capital Partners’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.43M Buy
+118,345
New +$8.24M 0.48% 56
2025
Q4
Sell
-269,926
Closed -$18.2M 81
2025
Q3
$18.2M Buy
269,926
+74,577
+38% +$5.9M 1.16% 34
2025
Q2
$17.1M Buy
+195,349
New +$15.3M 1.2% 36
2025
Q1
Sell
-413,498
Closed -$32.2M 71
2024
Q4
$32.2M Buy
+413,498
New +$30.6M 2.83% 8

Other funds holding DXCM

Meridiem Capital Partners's DXCM Position: Q1 2026 in Review

Meridiem Capital Partners opened a new position in DexCom (DXCM) in Q1 2026: 118,345 shares worth $7.43M. The stake represents 0.48% of the portfolio and ranks #56 among its holdings. This is a return to the name: Meridiem Capital Partners previously reported a position in DXCM as recently as Q3 2025.

Meridiem Capital Partners first reported a position in DXCM in Q4 2024 and has held it in 4 quarters since. The position peaked at $32.2M in Q4 2024. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Meridiem Capital Partners held 118,345 shares of DexCom worth $7.43M as of Q1 2026.
  • DexCom was a new Meridiem Capital Partners position in Q1 2026.
  • DexCom made up 0.48% of Meridiem Capital Partners's portfolio in Q1 2026, its #56 holding.
  • Meridiem Capital Partners first reported a position in DexCom in Q4 2024 and has held it in 4 quarters since.
  • Meridiem Capital Partners's DexCom position peaked at $32.2M in Q4 2024.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Meridiem Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.